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Introduction: Chronic tinnitus is a condition estimated to affect 10–15% of the
population. No treatment has shown efficacy in randomized clinical trials to reliably and
effectively suppress the phantom perceptions, and little is known why patients react
differently to the same treatments. Tinnitus heterogeneity may play a central role in
treatment response, but no study has tried to capture tinnitus heterogeneity in terms
of treatment response.
Research Goals: To test if the individualized treatment response can be predicted using
personal, tinnitus, and treatment characteristics.
Methods: A survey conducted by the web platform Tinnitus Hub collected data of
5017 tinnitus bearers. The participants reported which treatments they tried and the
outcome of the given treatment. Demographic and tinnitus characteristics, alongside with
treatment duration were used as predictors of treatment outcomes in both an univariate
as well as a multivariate regression setup. First, simple linear regressions were used with
each of the 13 predictors on all of 25 treatment outcomes to predict how much variance
could be explained by each predictor individually. Then, all 13 predictors were added
together in the elastic net regression to predict treatment outcomes.
Results: Individual predictors from the linear regression models explained on average
2% of the variance of treatment outcome. “Duration of treatment” was the predictor
that explained, on average, most of the variance, 6.8%. When combining all the
predictors in the elastic net, the model could explain on average 16% of the deviance of
treatment outcomes.
Discussion: By demonstrating that different aspects predict response to various
treatments, our results support the notion that tinnitus heterogeneity influences the
observed variability in treatment response. Moreover, the data suggest the potential of
personalized tinnitus treatment based on demographic and clinical characteristics.
Keywords: tinnitus, heterogeneity, crowdsensing, smart device, personalized treatment
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1. INTRODUCTION
Tinnitus is a condition characterized by an auditory perception,
usually in the form of ringing or hissing, for which there
is no corresponding external source (1). The prevalence of
tinnitus has been estimated between 10 and 15% in the adult
population (2, 3). From those, one fifth will require clinical
intervention (4). Additionally, the mean annual cost of illness
was estimated at 6.8 billion euros globally (5). On the individual
level, tinnitus may be accompanied by comorbidities such as
insomnia, anxiety and depression, constituting a high burden
to patients (6). Current clinical guidelines recommend that
clinicians target those potential comorbidities, and although
no treatment has shown efficacy in randomized clinical trials
to reliably and effectively suppress the phantom perceptions,
it is clear that various treatment options result in different
degree of improvements—most likely because of the underlying
heterogeneity of the etiology and pathophysiology of tinnitus
(2, 7, 8). The clinical guidelines also recommend different
management strategies for tinnitus, including, but not limited
to, psycho-education, counseling, cognitive behavior therapy,
hearing aids when assessed as necessary and sound therapy (2).
Importantly, the current clinical understanding is that certain
treatments may not be suitable/effective for all, and clinicians
should recommend treatments to patients in an individual basis
(8). Thus, albeit the low evidence levels for treatments on a group
level, these same treatments may be beneficial in specific cases on
the individual level.
From a clinical perspective, bothersome, chronic, and
subjective tinnitus is a common and challenging form of
tinnitus (2, 6). However, this form of tinnitus might be highly
heterogeneous. In recent years, the notion of tinnitus as a
complex, multi-faceted condition gained traction (9). For that
reason, researchers and clinicians have drawn their attention to
the different ways of tinnitus manifestation, including its etiology
(e.g., sound blast, persistent loud noise exposure, whiplash, etc.),
phenotype (e.g., type of sound perceived, laterality of the sound
perception, presence of hearing loss, etc.), and accompanying
comorbidities (e.g., insomnia, depression, anxiety, etc.). Such
heterogeneity constitutes a complex puzzle that challenges
both researchers and clinicians in their understanding of the
pathophysiology of tinnitus and in the development of new
treatments (1). Importantly, tinnitus heterogeneity may account
for the low success rates of clinical trials at the group level,
as well as why certain individuals respond positively to specific
treatments (8, 10).
Noteworthy efforts to capture tinnitus heterogeneity
include the studies from Langguth et al. (11), Tyler et al.
(12) and Van den Berge et al. (13). Overall, the studies
showed modest results without a clear delineation of
tinnitus subtypes. However, those studies were limited
due to sample size and/or homogeneous samples recruited
from specialized tinnitus clinics. It is yet unclear how
representative samples from tertiary clinics represent the
whole tinnitus population; thus, we consider a broader data
sample necessary to capture a yet unexplored facet of tinnitus
heterogeneity (14).
Crowdsourced health research studies have been proposed as
a mean to circumvent the difficulties experienced during patient’s
recruitment, such as the increased costs of adding participants
to a study and the homogeneous sample representation from
tertiary clinics (15). Crowdsourcing can be defined as the
collaborative collection of data in which individuals and/or
institutions participate voluntarily (15, 16). When the data is
collected through mobile devices, such as smartphones, tablets,
or wearable devices, the term crowdsensing is commonly used
(17). The number of policy makers, health providers and
academics using such technologies increased drastically in the
last decade due to the ubiquity of mobile and sensing devices
(18). Especially in tinnitus research, crowdsensing has been
substantially used (14, 17, 19, 20). Importantly, such technologies
may yield new insights about phenomena hardly accessible to
traditional settings.
To the best of our knowledge, no study tried to capture
tinnitus’ heterogeneity using crowdsensing technology, especially
in terms of treatment response. Our study aims to fill
that research gap. We collected crowdsensed data from
an online tinnitus self-help platform to explore tinnitus
heterogeneity avoiding the aforementioned limitations during
data collection, namely the reduced sample size and/or
homogeneous patient representation. First, we investigated
whether tinnitus heterogeneity could be expressed not only
TABLE 1 | Sample size of each treatment.
Treatment n
Self Sound Stimulation 1,562
Supplements and Herbal 1,157
Antidepressants 785
Hearing Aid 681
Acunpuncture 621
Masker 503
Chiropractor 489
Homeopathic 425
Psychologist 388
Cognitive Behavior Therapist 371
Tinnitus Retraining Therapy 370
Steroids 346
Off-label Medication 312
Psychiatrist 298
Neurofeedback / Meditation 270
Books / self help 254
Gabaergic medication 237
Notched Music 223
Soundcure 144
Acoustic Neuromodulation 120
Neuromonics 95
Low Level Laser Therapy 65
Retigabbine 53
Hyperbaric Oxygen Therapy 46
Transcranial Magnetic Stim. 45
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TABLE 2 | Sample’s demographic and tinnitus characteristics.
Predictor Levels n Percentage
Gender Male 1,712 58.8%
Female 1,181 40.5%
Other 21 0.7%
Age Under 18 13 0.4%
18–24 162 5.6%
25–34 364 12.5%
35–44 427 14.7%
45–54 606 20.8%
55–64 869 29.8%
65–74 405 13.9%
75 + 58 2.0%
Prefer not to say 10 0.3%
Tinnitus onset Less than 3 months 147 5.0%
4–6 months 156 5.4%
6–12 months 293 10.1%
1–2 years 427 14.7%
2–3 years 359 12.3%
3–5 years 347 11.9%
5–10 years 388 13.3
10–20 years 339 11.6%
20 + years 458 15.7%
Noise
reactiveness
Sounds have no affect 587 20.1%
Some sounds make it a lot
worse
627 21.5%
Some sounds make it
somewhat worse
354 12.1%
Some sounds make it better
and some make it worse
725 24.9%
Some sounds make it
somewhat better
212 7.3%
Some sounds make it a lot
better
113 3.9%
NA 296 10.2%
Hyperacusis No 1,006 34.5%
Mildly 795 27.3%
Moderately 776 26.6%
Severely 291 10.0%
NA 96 3.3%
Somatic No 1,643 56.4%
Yes 1,056 36.2%
NA 215 7.4%
Jaw and neck
problems
Problems with Jaw 261 9.0%
Problems with Neck 503 17.3%
Problems with Jaw and Neck 407 14.0%
NA 1,743 59.8%
Hearing loss Mild hearing Loss 1,265 43.4%
Moderate hearing loss 400 13.7%
Severe hearing loss 152 5.2%
NA 1,097 37.6%
Laterality of
hearing loss
Both ears 699 24.0%
One ear 1,119 38.4%
NA 1,096 37.6%
(Continued)
TABLE 2 | Continued
Predictor Levels n Percentage
Tinnitus
frequency
Low (<1 kHz) 152 5.2%
Mid (1–3kHz) 151 5.2%
Mid high (3–8 kHz) 525 18.0%
Very high (8 kHz +) 350 12.0%
Several dis in Hearing 77 2.6%
Unsure 563 19.3%
Na 1,096 37.6%
Perception of
tinnitus
One ear 688 23.6 %
Both ears 1,031 35.4 %
More in the brain 204 7 %
In the ears and brain 952 32.6 %
Not sure 39 1.3 %
Perception of
tinnitus during
the day
Does not change at all 774 26.6 %
Fluctuates, no pattern 1,369 46.9 %
Fluctuates, better in the
morning
131 4.5 %
Fluctuates, better in the
evening
626 21.4 %
NA 14 0.4 %
in terms of phenotype, etiology and comorbidities as has
previously been done, but also in terms of treatment response.
To investigate this hypothesis, we modeled each predictor
(i.e., tinnitus characteristics and demographics) individually
as an independent variable on single linear regressions with
treatment outcomes for 25 different treatments as dependent
variables. Second, we investigated whether tinnitus heterogeneity
could predict treatment response from demographic factors and
tinnitus characteristics. We operationalized this hypothesis by
combining all predictors in a statistical model to predict the
outcome of treatments.
2. METHODS
Data for our sample were collected by Tinnitus Hub. Founded
in 2015 by SH and MV, the Tinnitus Hub operates “Tinnitus
Talk” (www.tinnitustalk.com), created in 2011, the largest online,
anglophone self-help platform for tinnitus patients. The survey
took place between February 8th and March 13th of 2016.
Members of the forum received a link to the digital survey.
We collected information of 5017 participants, from those 2916
reported trying at least one treatment and thus were included in
the data set for the final analysis. It was not possible to obtain
written informed consent from the users of Tinnitus Talk, but
the “Terms and Rules” of the website informed the users that the
collected data will be analyzed for scientific purposes. All the data
were saved anonymously. A similar dataset was used in a former
study (14).
Personal and tinnitus information was collected from
participants of the survey alongside questions about which
tinnitus-related treatments were tried and were used as
independent values in our statistical models. In total, 13
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factors were included in our analysis (Table 2). Additionally,
participants were asked to rate how effective a given treatment
was in reducing the distress and/or suppressing the noise
perception, and the duration of the treatment retrospectively (1:
“this treatment made my tinnitus much worse,” 2: “this treatment
made my tinnitus mildly worse,” 3: “this treatment had no effect
on my tinnitus,” 4: “this treatment made my tinnitus slightly
better,” and 5: “this treatment made my tinnitus much better”).
Our analysis included the outcome of 25 different treatments
and used as dependent variables in our statistical model.
Participants consented to have their anonymous data used for
scientific research. Simple linear regressions were performed
for individual predictors (i.e., demographics and tinnitus
characteristics, and treatment duration) on treatment outcomes
(i.e., dependent variable). Regressions were weighted based on
the number of treatments that patients tried and p-values were
adjusted for multiple comparisons using Hommel correction
(21, 22). Collinearity was assessed with the variance inflation
factor (VIF). The VIF is the ratio of variance in a model with
multiple predictors, divided by the variance of a model with one
predictor alone (23). The high VIF values in ourmodels indicated
that models containing all 13 demographic factors and tinnitus
characteristics as predictors would contain high collinearity. To
address this issue, we used elastic net regularization (24). Elastic
net accounts for collinearity by penalizing the coefficients in the
model either by shrinking their values or by setting them to
0 (24). We ran a n-fold cross validated elastic net to estimate
the optimal lambda (i.e., one of the penalizing coefficients from
elastic net) over 11 different alpha values ranging from 0 (i.e.,
RIDGE regression) to 1 (i.e., Lasso Regression). For this analysis,
the predictors encoded as factors were converted into dummy
variables as a prerequisite from the statistical software. We
FIGURE 1 | Amount of variance explained in the linear regression models by each predictor across all different 25 treatments.
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selected the models with minimized mean squared error for our
final analysis.
All statistical analysis was conducted with R statistical
software (25), alongside the “tidyverse” package (26). Power
analysis were calculated using the "effsize" package (27) and
the elastic net was performed by the "GLMnet" package (24).
Non-parametric tests were used when statistical assumptions
of parametric tests were not met. P-values below 0.05 were
considered statistically significant.
3. RESULTS
Table 1 shows the frequency of each treatment in our sample.
Clinical and demographic characteristics of the sample are
summarized in Table 2. First, we applied linear regression
models with individual predictors as independent variables on
the self-reported treatment outcomes as dependent variables.
The aim of this analysis was to test how much variance
could be explained by individual predictors for the different
treatments. Figure 1 shows the average amount of variance
explained by each predictor on all 25 different treatments.
A summary of all statistical models can be found in the
Supplementary Materials. The amount of variance explained
by single predictors over all treatments was 2% on average.
FIGURE 2 | Mean amount of variance explained by type of predictor. Error
bars represent standard deviation. “Personal Characteristics” contains the
predictors Age, Gender, and Tinnitus Onset. “Tinnitus Characteristics”
contains the predictors Tinnitus Frequency, Laterality of Hearing Loss,
Perception of Tinnitus, Reactiveness to Noise, Hearing Loss, Laterality of
Tinnitus, Hyperacusis, and Jaw/Neck Problems. “Treatment Characteristics”
contains the predictor Treatment Duration.
Next, we investigated what type of predictor could explain
most of the variance of treatment outcomes. For this analysis,
we grouped predictors in three groups: personal, tinnitus
and treatment characteristics (Figure 2). Personal and tinnitus
characteristics could explain, on average, the same amount
of variance.
As shown in Figures 1, 2, the predictor “Duration of
Treatment” explained on average more variance than the
remaining predictors (p <0.05). To further explore the
relationship between treatment duration and treatment
outcome, we clustered the average treatment outcomes based
on their duration. The results can be found in Figure 3, where
our analysis of variance showed no trend of time over treatment
outcome (p= 0.99).
Next, we fitted all predictors as independent variables and self-
reported treatment outcomes as the dependent variable in our
elastic net regression model. This analysis aimed to measure how
much of the deviance on treatment outcomes can be explained
by combining all analyzed items. Figure 3 shows the amount of
deviance explained by all predictors for each of the 25 treatments.
On average, 16% of the deviance could be explained by all
predictors combined. Table 3 summarizes which predictors were
considered statistically significant by the elastic net and linear
regressions respectively.
Lastly, we conducted one exploratory analysis based on
the coefficients obtained by both models to identify clinical
markers of treatment success. From coefficients estimated by
linear regression, we observed that participants who reported
responding positively to sounds (i.e., rating a 4 or 5 in the
Likert scale) reported more frequently benefiting positively
to treatments with an acoustic component. Thus, we subset
only patients who reacted positively to sounds and divided
treatments with and without an acoustic component (Figure 4).
Our group mean comparison analysis corroborated our data-
driven hypothesis, as patients who reported reacting positively
to sounds also reported higher outcomes with treatments with an
acoustic component (p= 0.02, Cohen’s d= 1.07).
4. DISCUSSION
In this study we investigated whether personal, tinnitus, and
treatment characteristics collected from an internet self-help
platform population can be used to explain which patients are
responding to different treatments. Similar attempts to predict
treatment outcomes with patients’ characteristics have been
tried in a spectrum of mental conditions, including lower back
pain (28), depression (29), post traumatic stress disorder (30),
obsessive-compulsive disorder (31), substance abuse (32), and
tinnitus itself (33). To the best of our knowledge, this is the
first study attempting to capture tinnitus’ heterogeneity in terms
of a wide range of treatment responses using crowdsensing
technology. Moreover, whereas most studies tried to predict the
outcome of a single treatment, our study aimed to predict the
outcome of 25 different treatments.
Our results showed that 2% of the variance of treatment
outcomes could be explained, on average, by individual
Frontiers in Public Health | www.frontiersin.org 5 June 2019 | Volume 7 | Article 157
S
im
o
e
s
e
t
a
l.
To
w
a
rd
P
e
rso
n
a
lize
d
T
in
n
itu
s
Tre
a
tm
e
n
t
TABLE 3 | Predictors identified as significant by the elastic net model (X) and by linear regressions (O).
Duration of
treatment
Laterality of
hearing loss
Fluctuation of
sound perception
Noise
reactiveness
Jaw/Neck
problems
Onset Age Hyperacusis Gender Tinnitus
frequency
Hearing
loss
Somatic Laterality
of tinnitus
Acoustic
Neuromodulation
X X X X X X X X X X X
Hearing aid X/O X/O X X/O X/O X/O X X X X X/O O
Self Admin. Sound
Therapy
X/O X X/O X/O X X X X X/O X
TRT X/O X X X X X X/O X X X/O
Antidepressants X/O X X/O X X X X/O X/O X
Soundcure X/O X X X X X X X X/O
Psychiatrist X X X X X X X X X
Psychologist X X X/O X X X X X X
Supplements/Herbal
admin.
X X X X X X X X
Homeopathic
admin.
X X X X X X X X
GABA admin. X/O O X/O X/O X X X
In ear masker X/O X X O X X X
Acunpuncture X X X X/O X X X/O
Hyperbaxic
Oxygen Therapy
X X X X X X
Notched music X/O X/O X X X
Off Label
Medication admin.
X X X X X
Self learning X X X X X
CBT X X/O X O
Chiropractor X X
Neurofeedback X/O X
Steroids admin. X X
LowLevelLaser
Therapy
X
Neuromonics X
Retigabine admin. X
Transcranianl
Magnetic Stim.
X
Coefficients associated with significant predictors can be found in Supplementary Materials.
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FIGURE 3 | Amount of variance explained by the Elastic Net model with all the 13 predictors added simultaneously. HBOT, Hyperbaric Oxygen Therapy; TRT, Tinnitus
Retraining Therapy; TMS, Transcranial Magnetic Stimulation; CBT, Cognitive Behavior Therapy.
predictors (Figure 2). Additionally, our analysis showed that
both personal characteristics and tinnitus characteristics, despite
being significant predictors for multiple treatments (Table 3),
could explain little variance on average. At first glance, it
seems that the analyzed parameters have only a small impact
on treatment outcome, but the average amount of deviance
explained by the elastic net combining all 13 predictors into
a single model was 16%, after accounting for covariance. We
identified multiple statistically significant predictors in both
regression setups (Table 3), but the individual amount of
variance they could explain was limited. These results suggest
that although no single predictor is paramount to predict
the treatment outcomes, personal, tinnitus, and treatment
characteristics may have a predictive role when combined.
Altogether, those characteristics could be used in the future
to predict treatment responsiveness in tinnitus, especially
after better markers of treatment success are identified.
For instance, our analysis did not include information
about patients’ personality, depression or tinnitus-related
distress, nor did it collect information of the sequence in
which treatments were tried or whether treatments were
tried simultaneously.
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FIGURE 4 | Mean treatment outcomes on a 1–5 Likert scale clustered by
treatment duration.
Capturing tinnitus heterogeneity has been proposed
as an important clinical and scientific goal, but previous
attempts obtained limited results (12, 13). Importantly, tinnitus
heterogeneity may explain why only a subset of patients are
responding to specific treatments (10). A broader comprehension
of tinnitus, encompassing not only demographics and tinnitus
characteristics, but also treatment response, could, for example,
explain the limited treatment efficacy seen in clinical practice
(2). For instance, it is yet unclear whether previous successful
or unsuccessful treatments have any predictive power on the
outcomes of future treatments. Ultimately, the subtyping of
tinnitus could lead to personalized care, a long-standing request
by both clinicians and patients (6). Our results, though modest,
suggest that personalized treatment for tinnitus patients based
on patients’ personal, tinnitus, and treatment characteristics
should be feasible.
One example of future implications that this type of analysis
could lead to, is the effect of noise reactiveness in the outcomes of
treatments with and without an acoustic component (Figure 5).
Our results suggest that participants whose tinnitus respond
positively to sounds tend to benefit more from treatments
with an acoustic component than from treatment without such
component. Although future studies should try to replicate these
results, we believe that the insights from large data sets such as
these could have meaningful effects in tinnitus care and research.
For instance, such insights could help researchers define new,
fine-grained inclusion criteria for future clinical trials in acoustic-
based treatments.
Regarding treatment duration, the predictor that could,
on average, explain most of the variance, did not show any
statistically significant difference between time periods. These
results should be interpreted with caution as it is well-known that
certain treatments, such as cochlear implants, require some time
for adaptation whereas other treatments, such as antidepressants,
require longer periods to be effective. Nonetheless, our results
support the notion that the duration of treatment is not
inherently beneficial or detrimental to the treatment’s efficacy.
Our study comes with some inherent limitations. First, we
did not have access to information about treatments which were
performed in an overlapping span of time, thus we were unable to
account for possible interaction between treatments. Second, our
outcome measure was retrospective and subjective, which could
have biased the results. We consider a subjective metric, although
coarser than an objective one such and the Tinnitus Handicap
Inventory, adequate for this type of analysis given the multiple
treatments that a single patient tried and the sometimes-long
period of time between the administration of a treatment and
the survey. Nevertheless, further prospective studies analyzing
outcome predictors would be desirable. Third, although we
examined 25 different treatments, this number was insufficient
to capture the whole complexity of available interventions for
tinnitus treatments. Cognitive Behavior Therapy (CBT), for
example, can be performed in a span of days or months, sessions
can be individual or in group, a wide range of techniques can be
applied in each session, etc. Such variety of treatment details and
subtypes were not exclusive to CBT, but rather a commonality
across treatments. Fourth, we chose a limited number of potential
predictors for the survey, but we might have missed other
important items. Particularly we would expect that there may
exist further items that may be relevant for response to some
of the investigated treatments. Finally we are aware that the
investigated sample, albeit large and international, might not be
representative of all patients with tinnitus (14).
5. CONCLUSION
Our results suggest that tinnitus heterogeneity could be expressed
in terms of treatment response. The variance explained by
individual predictors on treatment outcomes suggests that
specific traits could explain why certain people are responding
positively to a given treatment. In the future, especially with the
availability of “big” multi-faceted data, a better understanding of
the factors involved in treatment responsiveness could lead to
individualized, optimal tinnitus management.
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FIGURE 5 | Mean treatment outcomes on a 1–5 Likert scale clustered by treatments with an acoustic component (yellow) and without an acoustic component (blue).
Error bar accounts for the standard deviation across all 25 treatments. TRT, Tinnitus Retraining Therapy; CBT, Cognitive Behavior Therapy; TMS, Transcranial
Magnetic Stimulation; HBOT, Hyperbaric Oxygen Therapy.
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